2Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003; 124: 778-790.
3Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997; 26 Suppl 1: 13-22.
4Hall PD, Plummer JL, Ilsley AH, Cousins MJ. Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low- dose" carbon tetrachloride vapor in the rat. Hepatology 1991; 13: 815-819.
5Buko VU, Sadovnichy VV. Cytochrome P-450 and free radical generation in rat liver microsomes under the influence of prostaglandin E1. Biochem Mol Biol Int 1996; 39: 1177-1184.
6Baek Y, Nakano H, Kumada K, Nagasaki H, Kigawa G, Sasaki J, Kaneda M, Hatakeyama T, Kitamura N, Sanada Y, Midorikawa T, Yamaguchi M. Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy. Hepatogastroenterology 1999; 46: 1836-1841.
7Masaki N, Ohta Y, Shirataki H, Ogata I, Hayashi S, Yamada S, Hirata K, Nagoshi S, Mochida S, Tomiya T. Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury. Gastroenterology 1992; 102: 572-576.
8Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761-767.
9Hanazaki K, Kuroda T, Kajikawa S, Amano J. Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion. Hepatogastroenterology 2000; 47: 807-811.
10Wang XE, Watanabe S, Oide H, Hirose M, Itatsu T, Osada T, Takazakura Y, Yokoi Y, Sato N. Hepatic stellate cell contraction is inhibited by lipo-prostaglandin E1 in vitro. J Gastroenterol Hepatol 1998; 13 Suppl: S14-S18.
